Fed. Circ. Rejects Email-Deleting Glaucoma Co.'s Plea
Ivantis Inc. needs to wait until after a patent infringement trial ends to appeal an order letting the jury presume emails the glaucoma treatment company deleted would have hurt its defense,...To view the full article, register now.
Already a subscriber? Click here to view full article